Form 4: Novavax Executive John Trizzino Reports Stock Transactions

EVP, CCO, and CBO of Novavax, John Trizzino, reports the acquisition and disposal of common stock and restricted stock units.

Summary

• On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax, reported transactions involving Novavax common stock and Restricted Stock Units (RSUs).
• Trizzino acquired 655 shares of common stock upon the vesting of RSUs.
• He disposed of 317 shares of common stock to cover tax obligations at a price of $13.9 per share.
• Following these transactions, Trizzino directly owns 28,310 shares of Novavax common stock.
• The reported RSUs vest in three equal installments on the anniversaries of the grant date, contingent upon continued employment.

Sentiment

Score: 5

Explanation: This is a routine filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The RSUs vest over a three-year period, contingent on continued employment.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation packages. These transactions are closely monitored by investors for insights into management's perspective on the company's performance and future prospects.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.

Key Dates